Literature DB >> 22426925

Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases.

Hideki Ogiwara1, Kapila Kalakota, Sunpreet S Rakhra, Irene B Helenowski, Maryanne H Marymont, John A Kalapurakal, Minesh P Mehta, Robert B Levy, James P Chandler.   

Abstract

The objective of this study is to evaluate the patterns of relapse and survival trends in patients with single brain metastases treated with post-operative adjuvant Gamma knife stereotactic radiosurgery (GKS) without whole brain radiotherapy (WBRT). Retrospective analysis of all consecutive patients who underwent GKS to the tumor cavity following resection of solitary brain metastasis was performed at a single institution. Between March 2001 and June 2010, 56 patients underwent GKS to the resection cavity following resection of intracranial metastases; no patient received pre- or post-operative WBRT as an adjuvant (salvage WBRT was permissible). The mean marginal dose was 17.1 Gy (range 14-20 Gy). The mean follow-up period was 24 months (range 3-99 months). Five patients (8.9%) had local recurrence in the immediate vicinity of the resection cavity, qualifying as "local failures", and 21 (37.5%) recurred at distant intracranial sites. Median intracranial recurrence free survival was 13 months. Median overall survival was 20.5 months. Salvage interventions were required in 26 patients, and included repeat radiosurgery in 17 patients, further surgery in two patients, and salvage WBRT in eight (14.3%; two of whom had also been locally salvaged with repeat radiosurgery) patients. As expected, avoidance of WBRT results in a high rate of intracranial failure (26/56 patients, 46%), even in well-selected patients with only single brain metastases. As anticipated, the majority of failures (21, 37.5%) are "distant intracranial", and in this well-selected cohort the local failure rate is low (5/56 patients, <9%). All patients failing intracranially (46%) are potential candidates for salvage therapies, but WBRT as salvage was utilized in only 14.3% of patients. The median intracranial relapse-free was 13 months and overall survival was 20.5 months.

Entities:  

Mesh:

Year:  2012        PMID: 22426925     DOI: 10.1007/s11060-012-0808-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  The dandelion effect: treat the whole lawn or weed selectively?

Authors:  Minesh Mehta
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

Review 2.  Management of brain metastases.

Authors:  Kristin A Bradley; Minesh P Mehta
Journal:  Semin Oncol       Date:  2004-10       Impact factor: 4.929

3.  Single session stereotactic radiosurgery boost to the post-operative site in lieu of whole brain radiation in metastatic brain disease.

Authors:  Matthew R Quigley; Russell Fuhrer; Stephen Karlovits; Brian Karlovits; Mark Johnson
Journal:  J Neurooncol       Date:  2008-01-09       Impact factor: 4.130

4.  The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group.

Authors:  B Borgelt; R Gelber; S Kramer; L W Brady; C H Chang; L W Davis; C A Perez; F R Hendrickson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-01       Impact factor: 7.038

5.  Radiation-induced dementia in patients cured of brain metastases.

Authors:  L M DeAngelis; J Y Delattre; J B Posner
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

6.  Tumor bed radiosurgery after resection of cerebral metastases.

Authors:  David Mathieu; Douglas Kondziolka; John C Flickinger; David Fortin; Brendan Kenny; Karine Michaud; Sanjay Mongia; Ajay Niranjan; L Dade Lunsford
Journal:  Neurosurgery       Date:  2008-04       Impact factor: 4.654

7.  Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.

Authors:  Ly Do; Richard Pezner; Eric Radany; An Liu; Cecil Staud; Benham Badie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-14       Impact factor: 7.038

8.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

9.  Boost radiosurgery for treatment of brain metastases after surgical resections.

Authors:  Yoshiyasu Iwai; Kazuhiro Yamanaka; Toshihiro Yasui
Journal:  Surg Neurol       Date:  2008-02

10.  A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases.

Authors:  Penny K Sneed; John H Suh; Steven J Goetsch; Seema N Sanghavi; Richard Chappell; John M Buatti; William F Regine; Eduardo Weltman; Vernon J King; John C Breneman; Paul W Sperduto; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-01       Impact factor: 7.038

View more
  11 in total

1.  Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry.

Authors:  Anthony L Asher; Mohammed Ali Alvi; Mohamad Bydon; Nader Pouratian; Ronald E Warnick; James McInerney; Inga S Grills; Jason Sheehan
Journal:  J Neurooncol       Date:  2021-01-22       Impact factor: 4.130

2.  The controversy surrounding the use of whole-brain radiotherapy in brain metastases patients.

Authors:  Minesh P Mehta
Journal:  Neuro Oncol       Date:  2015-07       Impact factor: 12.300

3.  HFSRT of the resection cavity in patients with brain metastases.

Authors:  Hanno M Specht; Kerstin A Kessel; Markus Oechsner; Bernhard Meyer; Claus Zimmer; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2016-03-10       Impact factor: 3.621

Review 4.  Tumor bed radiosurgery: an emerging treatment for brain metastases.

Authors:  Mark J Amsbaugh; Warren Boling; Shiao Woo
Journal:  J Neurooncol       Date:  2015-04-25       Impact factor: 4.130

5.  Stereotactic Radiosurgery to Prevent Local Recurrence of Brain Metastasis After Surgery: Neoadjuvant Versus Adjuvant.

Authors:  Ian E McCutcheon
Journal:  Acta Neurochir Suppl       Date:  2021

6.  Resection cavity radiosurgery for intracranial metastases: a review of the literature.

Authors:  Ying Zhang; Eric L Chang
Journal:  J Radiosurg SBRT       Date:  2014

Review 7.  Postoperative Cavity Stereotactic Radiosurgery for Brain Metastases.

Authors:  Eduardo M Marchan; Jennifer Peterson; Terence T Sio; Kaisorn L Chaichana; Anna C Harrell; Henry Ruiz-Garcia; Anita Mahajan; Paul D Brown; Daniel M Trifiletti
Journal:  Front Oncol       Date:  2018-08-31       Impact factor: 6.244

8.  Stereotactic radiosurgery boost to the resection cavity for cerebral metastases: Report of overall survival, complications, and corticosteroid protocol.

Authors:  Robert G Kellogg; David C Straus; Mehee Choi; Thymur A Chaudhry; Aidnag Z Diaz; Lorenzo F Muñoz
Journal:  Surg Neurol Int       Date:  2013-11-20

9.  Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases.

Authors:  Jennifer Vogel; Eric Ojerholm; Andrew Hollander; Cynthia Briola; Rob Mooij; Michael Bieda; James Kolker; Suneel Nagda; Geoffrey Geiger; Jay Dorsey; Robert Lustig; Donald M O'Rourke; Steven Brem; John Lee; Michelle Alonso-Basanta
Journal:  Radiat Oncol       Date:  2015-10-31       Impact factor: 3.481

10.  Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.

Authors:  Angelika Bilger; Eva Bretzinger; Jamina Fennell; Carsten Nieder; Hannah Lorenz; Oliver Oehlke; Anca-Ligia Grosu; Hanno M Specht; Stephanie E Combs
Journal:  Cancer Med       Date:  2018-05-09       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.